FACS analysis confirmed that at passage 10, 54.7% of EpCAM+ HBs co-expressed the proliferative marker Ki67, and immunostaining showed sustained co-expression of AFP, HNF4, and Ki67
Start your weight loss transformation with us and see the difference that dedicated, compassionate care can make
November 3, 2025: Trulicity Does Not Perform as Well as Competitor, New Study Finds A new study has found that people who took Trulicity had a higher risk of serious cardiovascular events and were more likely to die than people taking Ozempic
GLP-1 can disrupt your gut microbiome leading to diarrhea, consitpation, bloating, and abdominal pain
Your healthcare provider will work with you to find the best semaglutide dose
Tirzepatides dual agonist mechanism may accelerate progress, with some people reporting accelerated weight drops during the second month especially at doses above 10 mg (Journal of Clinical Medicine Research)